Dr. Corey's research focuses on lipid metabolism in patients with steatosis and steatohepatitis as well as the development of non-invasive biomarkers for the diagnosis and monitoring of non-alcoholic fatty liver disease. Dr. Corey also studies the interaction between obstructive sleep apnea and fatty liver disease. In addition, Dr. Corey participates in numerous clinical trials including studies for hepatitis B and C treatment and post-transplant prevention of hepatitis C infection.
No full-time research positions. I welcome contact from trainees and researchers interested in clinical or outcomes research in liver disease.